GO
Loading...

Minerva Neurosciences, Inc. (NASDAQ: NERV) to Ring The NASDAQ Stock Market Closing Bell

ADVISORY, July 3, 2014 (GLOBE NEWSWIRE) --

What:

Minerva Neurosciences, Inc. (Nasdaq:NERV), a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat neurosychiatric diseases, will visit the NASDAQ MarketSite in Times Square in celebration of its recent initial public offering.

In honor of the occasion, Rogerio Vivaldi, MD, MBA, President and Chief Executive Officer will ring the Closing Bell.

Where:

NASDAQ MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio

When:

Monday, July 7, 2014 – 3:45 p.m. to 4:00 p.m. ET

Minerva Neurosciences, Inc. Contact:
Media contact:
Jennifer Ringler
Berry & Company Public Relations
(212) 253-8881
jringler@berrypr.com

Investor contact:
Renee Leck
Stern Investor Relations
(212) 362-1200
renee@sternir.com

NASDAQ MarketSite:
Christine Barna
(646) 441-5310
Christine.Barna@nasdaqomx.com

Feed Information:
Fiber Line (Encompass Waterfront): 4463

Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
FEC 3/4
SR 13.235
DR 18.295411
MOD 4:2:0
DVBS QPSK

Social Media:

For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at: http://www.facebook.com/NASDAQ.

For photos from ceremonies and events visit our Instagram Page: http://instagram.com/nasdaq.

For news tweets, please visit our Twitter page at: http://twitter.com/nasdaqomx.

For exciting viral content and ceremony photos visit Tumblr Page: http://nasdaq.tumblr.com/.

Webcast:

A webcast of the NASDAQ Closing Bell will be available at: https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx.

Photos:

To obtain a hi-resolution photograph of the Market Close, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market close of your choice.

About Minerva Neurosciences, Inc. (Nasdaq:NERV):

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat central nervous system (CNS) diseases. Our strategy is to develop and commercialize products with transformative potential that will address critical unmet medical needs in the neuropsychiatric therapeutic area. We have identified and acquired or in-licensed a portfolio of development-stage proprietary compounds with innovative mechanisms of action. As we work to advance our current product pipeline, we plan to explore additional indications, identify new neuropsychiatric product candidates from our existing intellectual property, and acquire rights to promising product candidates with significant therapeutic potential. Our goal is to transform the lives of patients with improved therapeutic options and a patient-centric focus that will lead to groundbreaking advances in care in the years ahead.

About NASDAQ OMX Group

NASDAQ OMX (Nasdaq:NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents. Through its diverse portfolio of solutions, NASDAQ OMX enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. NASDAQ OMX is home to more than 3,400 listed companies with a market value of over $8.5 trillion and more than 10,000 corporate clients. To learn more, visit www.nasdaqomx.com.

-NDAQA-

Source:The NASDAQ OMX Group, Inc.